Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Wells Fargo & Company

BioMarin Pharmaceutical Inc.
Start price
€80.32
15.11.23 / 50%
Target price
€92.05
15.11.24
Performance (%)
-4.38%
Price
€76.80
07.05.24
Summary
This prediction is currently active. With a performance of -4.38%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 15.11.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioMarin Pharmaceutical Inc. 1.507% 1.507%
iShares Core DAX® 3.178% 0.980%
iShares Nasdaq 100 2.972% 0.925%
iShares Nikkei 225® 0.545% -4.556%
iShares S&P 500 2.367% 0.833%

Comments by Wells_Fargo___Compan for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -4.38%
Target price 92.050
Change
Ends at 15.11.24

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $100.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Wells Fargo & Company 
0
Report Share
15.11.23

Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€77.00
25.04.24
€102.63
25.04.25
-0.26%
07.05.24

Wells Fargo & Company 
25.04.24 50%